Loading clinical trials...
Loading clinical trials...
The Role of PET During Erlotinib Treatment to See the Responsiveness of Tumor Early in Patients With Non-small Cell Lung Cancer
Conditions
Locations
1
South Korea
Asan Medical Center
Seoul, SongPa-Gu, South Korea
Start Date
June 1, 2009
Primary Completion Date
May 1, 2010
Completion Date
December 1, 2011
Last Updated
October 27, 2009
NCT06305754
NCT05198830
NCT07485114
NCT05692635
NCT06066138
NCT06498635
Lead Sponsor
Asan Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions